Dalton Pharma Services (Dalton) provides pharmaceutical contract research services to pharmaceutical and research communities in Canada and internationally. The company is mainly focused on contract research, drug development services, process optimization, GMP peptide, kilo scale GMP pharmaceutical manufacturing, sterile fill, diagnostics, synthetic route development, synthetic feasibility analysis, natural products, scale up of difficult chemistry, heterocyclic and inert atmosphere chemistry, and drug analog development programs. Its products include cannabinoids, glitazones, coelenterazines, natural products, steroid products, nucleosides, phosphoramidites, and specialty compounds, as well as fentanyl salts, metabolites, and impurity products. The company caters its products and services to pharmaceutical, biotechnology, and academic institutions. The company was founded in 1986 and is headquartered in Toronto, Canada.